-
LabKey and Linguamatics Partner to Extract Clinical Insights from Big Data in Healthcare
Sep 25, 2018, 11:04 AM by Michael CroftCAMBRIDGE, N/A, UNITED KINGDOM - Sep 25, 2018 - Linguamatics, the leading natural language processing (NLP) text analytics provider, and LabKey, a provider of bioinformatics data management solutions, today announced an integrated solution designed to streamline the extraction and curation of valuable insights from large volumes of unstructured clinical notes and reportsFull story -
Quanticate partners with CluePoints™ to offer Data Quality Oversight
Sep 25, 2018, 04:31 AM by Michael CroftLONDON, UNITED KINGDOM - Sep 25, 2018 - Quanticate, a data-focused clinical research organisation (CRO), has announced that it has partnered with CluePoints to utilize their software to drive the statistical analysis to perform data integrity checks on all types of monitoring and investigator site data as part of its new Data Quality Oversight service that enables centralized statistical monitoring, in response to the amendments to the ICH Good Clinical Practice (GCP) E6(R2) guidelinesFull story -
BioIVT to Host the 2018 HEPATOPAC® User Group Meeting in Boston
Sep 24, 2018, 13:04 PM by Michael CroftWESTBURY, NY, US - Sep 24, 2018 - BioIVT, a leading provider of research models and services for drug development, today announced that it will be hosting the 2018 HEPATOPAC User Group Meeting (UGM) from 8:30 aFull story -
A $100 Million Biotech Deal Is Also A Tale Of Two Executives Facing Their Kids Deadly Diseases
Sep 21, 2018, 14:42 PM by Michael CroftForbes | Amicus Therapertics is purchasing a portfolio of ten gene therapies for $100 million. But there's more to this story than most business deals.Full story -
Canines-N-Kids Foundation To Host Symposium, Aims To Accelerate Drug Development For Child, Dog Cancers
Sep 21, 2018, 13:40 PM by Michael CroftFull storyBio-IT World News Brief | Canines-N-Kids Foundation is hosting the Paws for a Cure Research Symposium this November at the Merck Research Laboratories in Boston. The Foundation hopes to examine challenges and progress in accelerating cancer drug development for cancers shared between children and dogs.
-
H1 Launches “Strategy As A Service” Offering, Helps Life Sciences Companies Cut Time-To-Market In Half
Sep 21, 2018, 12:35 PM by Michael CroftFull storyBio-IT World News Brief | H1 launched a new Strategy as a Service offering designed to help clients accelerate the market research phase of drug development.
-
Cray Picks Up Two Supercomputer Wins In Asia
Sep 21, 2018, 07:22 AM by Michael CroftTOP500 | Cray has announced two new XC50 supercomputers that were purchased by research organizations in Japan and South Korea.Full story -
ABclonal Technology Unveils Next-Generation Sequencing Kits For Illumina Sequencing Platforms
Sep 20, 2018, 16:01 PM by Michael CroftBOSTON, MA, UNITED STATES - Sep 13, 2018 - ABclonal Technology, a dynamic and growing provider of biological reagents for life science research, today unveiled its new line of next-generation sequencing library preparation kits (NGS lib prep kits), one of the industrys highest-yielding DNA and RNA library preparation kitsFull story -
H1 Launches ‘Strategy as a Service’ Offering That Helps Life Sciences Companies Cut Time-to-Market in Half
Sep 20, 2018, 13:50 PM by Michael CroftNEW YORK CITY, NY, US - Sep 20, 2018 - FOR IMMEDIATE RELEASE Media contact:Michelle FaulknerFull story
+1 617-510-6998
michelle@big-swing -
Oxford Genetics extends its CRISPR Gene Editing Technology License Agreement from ERS Genomics to support its growth internationally
Sep 20, 2018, 08:34 AM by Michael CroftNEWCASTLE UPON TYNE, UNITED KINGDOM - Sep 20, 2018 - Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery, and ERS Genomics have extended their pre-existing non-exclusive, license agreement for the use of CRISPR gene editing technologyFull story -
Domainex appoints Dr Trevor Perrior as Chief Executive Officer
Sep 20, 2018, 06:07 AM by Michael CroftCAMBRIDGE, UK - Sep 20, 2018 - Domainex Ltd, a privately-owned drug research services company, is pleased to announce the appointment of Dr Trevor Perrior as Chief Executive Officer, effective from 1st October 2018Full story -
Novel deep learning drug discovery platform gets £1 million innovation boost
Sep 19, 2018, 04:39 AM by Michael Croft, UK - Sep 19, 2018 - Funding to support Artificial Intelligence (AI) in drug discovery takes a significant step forward today as Optibrium, Intellegens, and Medicines Discovery Catapult secure a grant from Innovate UK to fund a £1 million projectFull story -
Rho Recruiting New Team Members at SOCRA Annual Conference
Sep 18, 2018, 14:52 PM by Michael CroftCHAPEL HILL, NC, UNITED STATES - Sep 18, 2018 - WHAT: Rho, a full-service contract research organization (CRO), is hiring for a variety of clinical research positions, including clinical research associates (CRAs) and project managers, and will be looking to meet potential applicants during the upcoming Society of Clinical Research Associates (SOCRA) Annual Conference in New Orleans, Louisiana, September 28-30, 2018Full story -
Celebrating 10 Years of Sekisui XenoTech
Sep 18, 2018, 10:39 AM by Michael CroftKANSAS CITY, KS, UNITED STATES - Sep 18, 2018 - 10 years ago Sekisui Chemical Company acquired XenoTech and the future of the groundbreaking, innovative CRO was assuredFull story -
Seqster’s Perfect Timing, Powerful Platform Might Change Health
Sep 18, 2018, 10:25 AM by Michael CroftFull storyBio-IT World | Early adopters of Google Health or Microsoft Health Vault may remember the process of consolidating personal health records with a good deal of frustration or just a sense of futility. But Seqster, a privately-held health data management platform that emerged from stealth mode this past February, believes they have gotten it right this time.
-
Creative Biolabs Illustrated Its Newly-developed Antibody Affinity Maturation Service
Sep 18, 2018, 01:38 AM by Michael CroftSHIRLEY, NY - Sep 18, 2018 - Sep 18th, 2018, Creative Biolabs, as one of the most experienced supplier in various antibody production and engineering fields, has recently released its newly-developed affinity maturation antibody, which is an indispensable process to improve antibody affinity for an antigenFull story -
LifeArc® announces new CEO appointment
Sep 17, 2018, 08:16 AM by Michael CroftLONDON - Sep 17, 2018 - London, UK, September 4th, 2018. LifeArc, one of the UK's leading medical research charities, is delighted to announce the appointment of Melanie Lee, PhD, CBE as its new Chief Executive Officer (CEO), effective 1st November 2018Full story -
Identification of synthetic, macrocyclic, orally bioavailable cyclophilin inhibitors with potent HCV activity, published in The Journal of Medicinal Chemistry
Sep 17, 2018, 05:09 AM by Michael CroftCAMBRIDGE AND ONGAR, UK - Sep 17, 2018 - A paper entitled Discovery of a Potent and Orally Bioavailable Cyclophilin Inhibitor Derived from the Sanglifehrin Macrocycle by authors from Selcia, Cypralis and Gilead has been selected as a featured article by the editors of The Journal of Medicinal ChemistryFull story -
Creative Diagnostics Launches Recombinant HPV L1 VLP for Science Research
Sep 17, 2018, 04:54 AM by Michael CroftSHIRLEY, NY, UNITED STATES - Sep 17, 2018 - As a leader in the manufacture of raw materials, reagents and antibodies for biotechnology industry, Creative Diagnostics now establishes a global-leading virus-like particles (VLPs) manufacture platform using ExFull story -
Large-Scale Global Genome Projects Choose PacBio Sequencing To Help Decode Life
Sep 14, 2018, 08:20 AM by Michael CroftFull storyBio-IT World News Brief | The Vertebrate Genomes Project recently released the first 15 of an anticipated 66,000 high-quality reference genomes that will eventually include all vertebrate species on Earth.